Valuation
Is the price right?2/2 inputs reported · High confidence
- Share count up 7.7% (existing holders diluted)
Mixed versus peers:
- ▲ Earnings yield
- ▼ P/B
Behind the score
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
Bringing the fundamentals into focus…
Price as of close on Nov 3, 2026 · Financials updated Sep 30, 2026
2/2 inputs reported · High confidence
Mixed versus peers:
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
1/1 inputs reported · High confidence
Weaker than most peers on:
Earnings-per-share growth versus other banks and insurers.
2/2 inputs reported · High confidence
Stronger than most peers on:
Return on equity and return on assets versus other banks and insurers.
Not rated for banks and insurers: debt and share-price swings say little about their risk. We leave it blank rather than fill the gap with a made-up middle value.
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
Got weaker
| Previous quarter | Latest quarter | Change | |
|---|---|---|---|
| Revenue (12 months) | 32.3M USD | 32.6M USD | +1.0% |
| Net income (12 months) | 69.8M USD | 71.8M USD | +2.8% |
| Free cash flow (12 months) | 38.3M USD | 38.1M USD | −0.5% |
| Cash | 174.9M USD | 165.4M USD | −5.4% |
| Shares outstanding | 20.6M | 22.2M | +7.7% |
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Valuations in Banks - Regional are within their usual range since 2016.
| Key ratios | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | Change |
|---|---|---|---|---|---|---|
| Net margin | 216.1% | 200.2% | 179.5% | 208.9% | 213.7% | ▲ 4.8 pts |
| Return on assets (ROA) | 1.3% | 1.3% | 1.1% | 1.3% | 1.2% | ▼ 0.0 pts |
| Return on equity (ROE) | 15.8% | 18.2% | 14.6% | 14.7% | 13.6% | ▼ 1.1 pts |
Price history is added with the daily price update and will appear after the next one.